Announced Tue, 21 Jul · 15:49 IST
Independent Director P.S. Jayakumar completes 2nd term, ceases to be Director
Management Changes View source PDF
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.0%1-day move
₹1930.90
prior close
₹1920.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.6-1.3-1.6-1.8-3.0-2.5-0.8———————
Up moveDown movePending
AI summary
Mr. P.S. Jayakumar (DIN: 01173236) has completed his 2nd consecutive term as Independent Director of Emcure Pharmaceuticals and ceases to be a Director from close of business on July 21, 2026. He also steps down as Chairman of the Audit Committee and as Member of the Nomination and Remuneration Committee and Risk Management Committee. The Board has appreciated his contributions during his tenure.
Likely market impact
Routine governance update, no material impact on operations; the company will need to fill these committee positions.